These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 15591424)

  • 1. Epoetin alfa: future directions and future research.
    Ludwig H; Hudis CA; Goss G; Leyland-Jones B
    Oncologist; 2004; 9 Suppl 5():70-3. PubMed ID: 15591424
    [No Abstract]   [Full Text] [Related]  

  • 2. Recombinant human erythropoietin in pediatric oncology: a review.
    Feusner J; Hastings C
    Med Pediatr Oncol; 2002 Oct; 39(4):463-8. PubMed ID: 12203665
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anemia and response to epoetin alfa: the cause of anemia matters!
    Dharmarajan TS
    J Am Geriatr Soc; 2008 Aug; 56(8):1574-5. PubMed ID: 18808607
    [No Abstract]   [Full Text] [Related]  

  • 4. Report on epoetin use in oncology is precursor to guidelines.
    Levenson D
    Rep Med Guidel Outcomes Res; 2001 May; 12(11):8-9. PubMed ID: 12148526
    [No Abstract]   [Full Text] [Related]  

  • 5. Response to the publication: EORTC guidelines for the use of erythropoietic proteins in anaemic patients with cancer.
    Gascón P; Ludwig H
    Eur J Cancer; 2005 Dec; 41(18):2789-91. PubMed ID: 16253500
    [No Abstract]   [Full Text] [Related]  

  • 6. Quality of life and anemia: the nephrology experience.
    Macdougall IC
    Semin Oncol; 1998 Jun; 25(3 Suppl 7):39-42. PubMed ID: 9671329
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epoetin alfa. Clinical evolution of a pleiotropic cytokine.
    Henry DH; Bowers P; Romano MT; Provenzano R
    Arch Intern Med; 2004 Feb; 164(3):262-76. PubMed ID: 14769622
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Suboptimal hemoglobin levels: do they impact patients and their therapy? Introduction.
    Pecorelli S
    Semin Oncol; 2000 Apr; 27(2 Suppl 4):1-3. PubMed ID: 10847300
    [No Abstract]   [Full Text] [Related]  

  • 9. Erythropoietin and radiotherapy: a dangerous combination?
    Dunst J
    Strahlenther Onkol; 2004 Mar; 180(3):133-5. PubMed ID: 15032246
    [No Abstract]   [Full Text] [Related]  

  • 10. Antianemic effect of once weekly regimen of epoetin alfa 40,000 units in anemic cancer patients receiving chemotherapy.
    Voravud N; Sriuranpong V; Suwanrusme H
    J Med Assoc Thai; 2007 Jun; 90(6):1082-8. PubMed ID: 17624200
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased hemoglobin levels and improved quality-of-life assessments during epoetin alfa treatment in anemic cancer patients: results of a prospective, multicenter German trial.
    Reinhardt U; Tulusan A; Angermund R; Lutz H;
    Oncologist; 2005 Mar; 10(3):225-37. PubMed ID: 15793226
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Optimal hemoglobin levels for cancer patients.
    Itri LM
    Semin Oncol; 2000 Apr; 27(2 Suppl 4):12-5; discussion 16-7. PubMed ID: 10847303
    [No Abstract]   [Full Text] [Related]  

  • 13. Early Intervention with epoetin alfa during platinum-based chemotherapy: an analysis of quality-of-life results of a multicenter, randomized, controlled trial compared with population normative data.
    Savonije JH; van Groeningen CJ; Wormhoudt LW; Giaccone G
    Oncologist; 2006 Feb; 11(2):197-205. PubMed ID: 16476840
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Current and future challenges in anaemia management.
    Levin A; Locatelli F; Muirhead N; Ritz E
    Nephrol Dial Transplant; 2005 Jun; 20 Suppl 6():vi1-2. PubMed ID: 15958819
    [No Abstract]   [Full Text] [Related]  

  • 15. Anaemia of CKD--the CHOIR study revisited.
    Singh AK; Szczech L; Tang KL; Barnhart H; Sapp S; Wolfson M; Reddan D
    Nephrol Dial Transplant; 2007 Jul; 22(7):1806-10. PubMed ID: 17420166
    [No Abstract]   [Full Text] [Related]  

  • 16. [Anaemia treatment in gynaecology: use of epoetin in onco-gynaecology and gynaecological surgery].
    Kirchner V;
    Rev Med Suisse; 2005 Apr; 1(15):1041-3, 1046-7. PubMed ID: 15918284
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Randomized, double-blind, placebo-controlled trial of erythropoietin in non-small-cell lung cancer with disease-related anemia.
    Wright JR; Ung YC; Julian JA; Pritchard KI; Whelan TJ; Smith C; Szechtman B; Roa W; Mulroy L; Rudinskas L; Gagnon B; Okawara GS; Levine MN
    J Clin Oncol; 2007 Mar; 25(9):1027-32. PubMed ID: 17312332
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Randomized, double-blind, placebo-controlled trial of epoetin alfa in men with castration-resistant prostate cancer and anemia.
    Winquist E; Julian JA; Moore MJ; Nabid A; Sathya J; Wood L; Venner P; Levine M
    J Clin Oncol; 2009 Feb; 27(4):644-6. PubMed ID: 19103725
    [No Abstract]   [Full Text] [Related]  

  • 19. Chronic kidney disease, anemia, and epoetin.
    Riley DS
    N Engl J Med; 2007 Mar; 356(9):956; author reply 958-9. PubMed ID: 17329706
    [No Abstract]   [Full Text] [Related]  

  • 20. Anemia: dialysis patients experiences.
    Schatell D; Witten B
    Nephrol News Issues; 2004 Nov; 18(12):49-54. PubMed ID: 15595502
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.